High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome

Endocrine Journal

Volumn 60, Issue 6, 2013, Pages 743-752

  Rhee, Eun Jung ^a   Kim, Mee Kyoung ^b   Park, Se Eun ^a   Park, Cheol Young ^a   Baek, Ki Hyun ^b   Lee, Won Young ^a   Kang, Moo Il ^b   Park, Sung Woo ^a   Kim, Sun Woo ^a   Oh, Ki Won ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Metabolic syndrome; Nonalcoholic fatty liver disease; Vitamin D

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CALCIFEDIOL; CALCIUM; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN D;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; BODY MASS; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; RISK FACTOR; RISK REDUCTION; SCREENING TEST; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; VITAMIN BLOOD LEVEL;

ADULT; AGED; CALCIFEDIOL; CROSS-SECTIONAL STUDIES; FATTY LIVER; HEALTH; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; REPUBLIC OF KOREA; RISK FACTORS; YOUNG ADULT;

EID: 84875506039     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0387     Document Type: Article

References (39)

1. Day CP, James OF (1998) Hepatic steatosis: innocent bystander or guilty party? Hepatology 27: 1463-1466.
2. Hewison M, Gacad MA, Lemire J, Adams JS (2001) Vitamin D as a cytokine and hematopoetic factor. Rev Endocr Metab Disord 2: 217-227.
3. Hewison M (1992) Vitamin D and the immune system. J Endocrinol 132: 173-175.
4. Caldwell SH, Argo CK (2007) Divergent effects of per-oxisome proliferator-activated receptor-gamma ligands in human and mouse nonalcoholic steatohepatitis. Hepatology 46: 285-287.
5. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM (2004) Obesity and hepatocellular carcinoma. Gastroenterology 127: S97-S103.
6. Day CP, James OF (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
7. Caldwell SH, Crespo DM (2004) The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alco-holic fatty liver disease. J Hepatol 40: 578-584.
8. Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 76: 315-325.
9. Rosen CJ (2011) Clinical practice. Vitamin D insuffi-ciency. N Engl J Med 364: 248-254.
10. Kim MK, Baek KH, Song KH, Il Kang M, Park CY, et al. (2011) Vitamin D deficiency is associated with sarcope-nia in older Koreans, regardless of obesity: the Fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009. J Clin Endocrinol Metab 96: 3250-3256.
11. Chagas CE, Borges MC, Martini LA, Rogero MM (2012) Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4: 52-67.
12. Lim S, Shin H, Kim MJ, Ahn HY, Kang SM, et al. (2012) Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean Longitudinal Study on Health and Aging. J Clin Endocrinol Metab 97: 169-178.
13. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, et al. (2012) Low Serum 25-Hydroxyvitamin D Is Associated with Increased Risk of the Development of the Metabolic Syndrome at Five Years: Results from a National, Population-Based Prospective Study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 97: 1953-1961.
14. Kim MK, Il Kang M, Oh KW, Kwon HS, Lee JH, et al. (2010) The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol 73: 330-338.
15. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, et al. (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66: S98-S112.
16. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A (2006) Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 21: 889-897.
17. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, et al. (2007) Associations between serum 25-hydroxyvi-tamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17: 517-524.
18. Manco M, Ciampalini P, Nobili V (2010) Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology 51: 2229.
19. Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, et al. (2011) Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 55: 415-425.
20. Katz K, Brar PC, Parekh N, Liu YH, Weitzman M (2010) Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. J Obes 2010:496829.
21. Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, et al. (2012) Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activa-tion. Hepatology 55: 1103-1111.
22. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, et al. (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9: 85.
23. List of NGSP Certified Methods. Available at http://www.ngsp.org/docs/method.pdf. Lastly accessed 26th November, 2012.
24. Schwartz KL, Monsur JC, Bartoces MG, West PA, Neale AV (2005) Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study. BMC Fam Pract 6: 28.
25. American Diabetes Association. Standards of medical care in diabetes-2010 (2010) Diabetes Care 33: S11-S61.
26. Matthews DR, Hosker JP, Rudenski AS, Baroni MG, Pozzilli P, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fast-ing plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
27. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
28. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S (2003) Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical back-ground. J Gastroenterol 38: 954-961.
29. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, et al. (1986) Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 146: 1011-1015.
30. Zúñiga S, Firrincieli D, Housset C, Chignard N (2011) Vitamin D and the vitamin D receptor in liver pathophys-iology. Clin Res Hepatol Gastroenterol 35: 295-302.
31. Holick MF, Frommer JE, McNeill SC, Richtand NM, Henley JW, et al. (1977) Photometabolism of 7-de-hydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun 76: 107-114.
32. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obe-sity. Am J Clin Nutr 72: 690-693.
33. Boucher BJ (2011) Vitamin D insufficiency and diabe-tes risks. Curr Drug Targets 12: 61-87.
34. Takiishi T, Gysemans C, Bouillon R, Mathieu C (2010) Vitamin D and diabetes. Endocrinol Metab Clin North Am 39: 419-446.
35. MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76: 1536-1538.
36. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, et al.; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group (2009) Global vita-min D status and determinants of hypovitaminosis D. Osteoporos Int 20: 1807-1820.
37. Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, et al. (2011) Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 96: 643-651.
38. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, et al. (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20: 133-140.
39. Joy D, Thava VR, Scott BB (2003) Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 15: 539-543.